Advances in Pharmaceutical Crystals: Numerical Simulations and Experimental Investigations
A special issue of Crystals (ISSN 2073-4352). This special issue belongs to the section "Industrial Crystallization".
Deadline for manuscript submissions: 20 September 2026 | Viewed by 1661
Editor
Interests: crystalisation; extraction; drying; transport phenomena; eutectic solvent; API solubility
Special Issue Information
Dear Colleagues,
The solid-state form of an active pharmaceutical ingredient, particularly its crystalline structure, is a critical determinant of drug product performance, influencing key properties such as solubility, stability, bioavailability and manufacturability. Understanding and controlling crystallization processes and final crystal forms are therefore paramount in pharmaceutical development. This field is being revolutionized by the powerful synergy between numerical simulations and advanced experimental investigations. Modern research leverages computational methods—including molecular dynamics, density functional theory and process modeling—to predict polymorphs, crystal habits and crystallization pathways. These simulations are intricately validated and guided by cutting-edge experimental techniques such as in situ spectroscopy, high-resolution X-ray diffraction and thermal analysis. This integrated approach accelerates the rational design of optimal pharmaceutical crystals with desired characteristics.
This Special Issue aims to compile high-quality original research and review articles that highlight recent progress at the intersection of computational and experimental studies of pharmaceutical crystals. Topics of interest include, but are not limited to:
- Advanced control of granulometric characteristics (size, shape and distribution) to improve flowability and processability.
- Strategies to improve solubility, stability and bioavailability through co-crystallization and the formation of multicomponent systems.
- Innovative use of plant components in the crystallization process to adjust active pharmaceutical ingredient.
- The role of numerical simulations in understanding and predicting crystal growth and phase transitions.
- New crystallization techniques and characterization methods for complex pharmaceutical systems.
- Prediction and stability assessment of polymorphs, hydrates and cocrystals.
- Computational screening for crystal structure and co-former selection.
- Process analytical technology and in situ monitoring of crystallization.
- Design and control of crystal size, shape and morphology.
- Interplay between crystal structure and bulk powder properties (flow and compaction).
- Novel experimental characterization techniques for crystal forms.
- Case studies on the integrated use of simulation and experiment in drug development.
Prof. Dr. Jasna Prlić Kardum
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Crystals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2100 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmaceutical crystals
- polymorphism
- cocrystals
- crystallization process
- molecular modeling
- process simulation
- in situ characterization
- crystal engineering
- solid-form screening
- computational pharmaceutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
